Navigation Links
Virogen Announces Launch of New Business Unit, "The Cannabis Connection", and Sets Sights on $15-20 Billion Legal Marijuana Market
Date:5/2/2013

SAN GERONIMO, Calif., May 2, 2013 /PRNewswire/ -- Virogen Inc. (OTC:VRNI), a holding company with specialties in data security and encryption technology, today announced the launch of its newest business unit, "The Cannabis Connection", which is intended to operate medicinal marijuana dispensaries in states that have legalized such operations, including California.

With an estimated current annual value of approximately $120 billion (legal and illegal) and expected continued easing of marijuana laws nationwide, the marijuana market appears to be headed for a period of dramatic growth.  In California, The Cannabis Connection's home state, which represents approximately 10% of the overall U.S. market, 95%, or approximately $11 billion, of marijuana sales are made legally through medicinal marijuana dispensaries. The company's management has equated the current state of the legal marijuana industry to the post-prohibition U.S. alcohol industry, in terms of the massive consumer market, volume of consumption, market fragmentation and opportunity for profit.

It is the fragmented nature of the legal marijuana market that provides the greatest source of optimism for the company's management. This highly fragmented market is dominated by independent operators, many of whom were "dealers" prior to the legalization of marijuana, who invested minimal capital and operate their marijuana outlets in areas where overhead is low. It is the market fragmentation coupled with the relative lack of sophistication of existing operators that provide the company with its opportunity to consolidate existing outlets and operate a chain of dispensaries, all within an extremely short timeframe.

About Virogen, Inc.

In addition to developing its recently announced business unit, The Cannabis Connection, Virogen, Inc. is a technology holding company. The company's wholly owned subsidiary, Tiger Team Technologies "T3," has developed a very unique suite of copyrighted tools to address the network and database security needs of enterprise level companies and corporations. T3's risk management offering provides an unprecedented level of security and liability protection, positioning it as one of the only companies with a comprehensive solution to data security breaches for its clients. T3's primary markets include medical service providers, financial services firms, brokerages and currency transaction platforms, consumer credit card companies, banking entities, retailers, defense and government related operations.

Forward-Looking Statements:

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Virogen, Inc. and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions the occurrence of unanticipated events or changes to future operating results.

Contact: Paul Hogan , paul@tigerteamtech.com, 415-488-6214


'/>"/>
SOURCE Virogen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardium Announces Generx Publication In Molecular Therapy
2. Medifirst Solutions, Inc. Announces New Healthcare And Wellness Division
3. Ferring Announces It Will Present Phase 3 Data for Cervical Ripening Agent at American College of Obstetricians and Gynecologists Annual Clinical Meeting
4. Abide Therapeutics Announces Collaboration With Merck to Develop Novel Therapies for Type 2 Diabetes and Metabolic Diseases
5. BD Announces Results For 2013 Second Fiscal Quarter
6. Sofinnova Ventures Announces Team Expansion and Promotion
7. PharmaRoth Labs, Inc. Announces Trading Symbol Change
8. Paratek Pharmaceuticals Announces Expanded FDA Grant of Qualified Infectious Disease Product (QIDP) Designation for Its Lead Product Candidate, Omadacycline
9. Sangamo BioSciences Announces First Quarter 2013 Conference Call and Webcast
10. GW Pharmaceuticals Announces Pricing of Initial Public Offering on the NASDAQ Global Market
11. Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized ... Top Workplaces National Standard. To learn more about ... ... Inc.) ... survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... Dec. 8, 2016  Pennsylvania Physician General Dr. ... and Alcohol Programs Gary Tennis released ... known as benzodiazepines, developed with the help of ... medications that are frequently prescribed for anxiety or ... used with opioid pain medications, benzodiazepines pose a ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 2016 , ... After enjoying record-breaking attendance at its last ... 33rd Annual Issues & Research Conference, March 2-3, 2017, at the Westin ... is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." 2016 ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused on ... efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, Jr. ... honored to team up with Upstage Lung Cancer in order to make major strides ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... Peachtree City, Ga (PRWEB) , ... December 08, ... ... and moving as soon after surgery as possible. With this in mind, SIGVARIS ... vein thrombosis (DVT or blood clot) during bed rest and provide the benefits ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... offices headquartered in Jefferson County, is announcing the launch of a charity drive ... The number of homeless women and children in Birmingham has grown steadily since ...
Breaking Medicine News(10 mins):